Position in NVS
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$3,889,476
+$430,758 QoQ
Shares Held
24,818
+9.6% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#309
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Integrated Wealth Concepts LLC holds $214,639,248 across 18 Drug Manufacturers - General names. NVS ranks #9 (1.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
60,927 | $73,077,677 | |
| 2 | JNJ |
Johnson & Johnson
|
162,906 | $41,373,236 | |
| 3 | MRK |
Merck & Co., Inc.
|
162,596 | $20,893,586 | |
| 4 | ABBV |
AbbVie Inc.
|
78,969 | $19,871,759 | |
| 5 | PFE |
Pfizer Inc
|
613,403 | $14,770,744 | |
| 6 | AMGN |
Amgen Inc
|
35,828 | $12,974,035 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
222,207 | $12,803,567 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
40,048 | $5,059,664 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,889,476 | 24,818 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $3,458,718 | 22,643 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $1,407,101 | 10,206 | Shares | Other | 2026-02-13 | |
| 2025-09-30 | $2,297,291 | 17,914 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $2,060,679 | 17,029 | Shares | Other | 2025-08-14 | |
| 2025-03-31 | $2,358,359 | 21,155 | Shares | Other | 2025-05-15 | |
| 2024-12-31 | $2,344,684 | 24,095 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $2,741,041 | 23,831 | Shares | Other | 2024-11-14 | |
| 2024-06-30 | $2,594,110 | 24,367 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $2,313,491 | 23,917 | Shares | Other | 2024-05-15 | |
| 2023-12-31 | $2,503,652 | 24,796 | Shares | Other | 2024-02-13 | |
| 2023-09-30 | $2,739,932 | 26,899 | Shares | Other | 2023-11-15 | |
| 2023-06-30 | $2,747,375 | 27,226 | Shares | Other | 2023-08-15 | |
| 2023-03-31 | $2,421,992 | 26,326 | Shares | Other | 2023-05-03 | |
| 2022-12-31 | $2,572,547 | 28,357 | Shares | Other | 2023-02-13 | |
| 2022-09-30 | $2,072,260 | 27,263 | Shares | Other | 2022-11-14 | |
| 2022-06-30 | $2,293,552 | 27,133 | Shares | Other | 2022-08-08 | |
| 2022-03-31 | $2,301,507 | 26,228 | Shares | Other | 2022-05-12 | |
| 2021-12-31 | $2,173,629 | 24,850 | Shares | Other | 2022-02-15 | |
| 2021-09-30 | $1,677,553 | 20,513 | Shares | Other | 2021-11-15 | |
| 2021-06-30 | $1,684,655 | 18,464 | Shares | Other | 2021-08-13 | |
| 2021-03-31 | $1,560,779 | 18,259 | Shares | Other | 2021-05-13 | |
| 2020-12-31 | $1,490,483 | 15,784 | Shares | Other | 2021-02-12 | |
| 2020-09-30 | $1,163,090 | 13,375 | Shares | Other | 2020-11-13 | |
| 2020-06-30 | $1,142,494 | 13,081 | Shares | Other | 2020-07-30 | |
| 2020-03-31 | $967,963 | 11,740 | Shares | Other | 2020-05-18 | |
| No filing history on record for this holder in this stock. | ||||||